Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Pre-Market Proof-of-Concept Study for Ex Vivo Raman Spectroscopy Measurements on Excised Lung Tissue With the Sentry System

NCT05790226 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05790226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05790226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Pre-Market Proof-of-Concept Study for Ex Vivo Raman Spectroscopy Measurements on Excised Lung Tissue With the Sentry System
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Terminated
Start date
January 9, 2023
Completion date
November 6, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer